Enolase 1 (ENO1) catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate and is highly expressed in gastric cancer, enhancing glycolytic flux and contributing to chemoresistance (28). Here, ENO1 is linked to gastric cancer.